nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
|
Konstadoulakis, Manousos M. |
|
2001 |
48 |
5 |
p. 417-420 |
artikel |
2 |
|
Safarjalani, Omar N. |
|
2001 |
48 |
5 |
p. 389-397 |
artikel |
3 |
|
Bunnell, Craig A. |
|
2001 |
48 |
5 |
p. 347-355 |
artikel |
4 |
|
DeHaan, Ryan D. |
|
2001 |
48 |
5 |
p. 383-388 |
artikel |
5 |
|
Mukohara, Toru |
|
2001 |
48 |
5 |
p. 356-360 |
artikel |
6 |
|
Makino, Masato |
|
2001 |
48 |
5 |
p. 370-374 |
artikel |
7 |
|
Friedman, Henry S. |
|
2001 |
48 |
5 |
p. 413-416 |
artikel |
8 |
|
Bos, A. |
|
2001 |
48 |
5 |
p. 361-369 |
artikel |
9 |
|
Song, Jinming |
|
2001 |
48 |
5 |
p. 339-346 |
artikel |
10 |
|
Hector, Suzanne |
|
2001 |
48 |
5 |
p. 398-406 |
artikel |
11 |
Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice
|
Friedman, Henry S. |
|
2001 |
48 |
5 |
p. 413-416 |
artikel |
12 |
A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma
|
Konstadoulakis, Manousos M. |
|
2001 |
48 |
5 |
p. 417-420 |
artikel |
13 |
Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen
|
Makino, Masato |
|
2001 |
48 |
5 |
p. 370-374 |
artikel |
14 |
Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy
|
Safarjalani, Omar N. |
|
2001 |
48 |
5 |
p. 389-397 |
artikel |
15 |
Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis
|
Song, Jinming |
|
2001 |
48 |
5 |
p. 339-346 |
artikel |
16 |
In vitro studies on the mechanisms of oxaliplatin resistance
|
Hector, Suzanne |
|
2001 |
48 |
5 |
p. 398-406 |
artikel |
17 |
Japanese experience with second-line chemotherapy with low-dose (60 mg/m2) docetaxel in patients with advanced non-small-cell lung cancer
|
Mukohara, Toru |
|
2001 |
48 |
5 |
p. 356-360 |
artikel |
18 |
Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats
|
Stecklair, Kataleeya P. |
|
2001 |
48 |
5 |
p. 375-382 |
artikel |
19 |
Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats
|
Stecklair, Kataleeya P. |
|
2001 |
48 |
5 |
p. 375-382 |
artikel |
20 |
Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours
|
Bos, A. |
|
2001 |
48 |
5 |
p. 361-369 |
artikel |
21 |
Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies
|
Bunnell, Craig A. |
|
2001 |
48 |
5 |
p. 347-355 |
artikel |
22 |
Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase
|
DeHaan, Ryan D. |
|
2001 |
48 |
5 |
p. 383-388 |
artikel |
23 |
Thymidine phosphorylase as a target for imaging and therapy with thymine analogs
|
Klecker, Raymond W. |
|
2001 |
48 |
5 |
p. 407-412 |
artikel |
24 |
Thymidine phosphorylase as a target for imaging and therapy with thymine analogs
|
Klecker, Raymond W. |
|
2001 |
48 |
5 |
p. 407-412 |
artikel |
25 |
Use of PEG-asparaginase in the treatment of patients with solid tumors
|
Pinheiro, João Paulo Vieira |
|
2001 |
48 |
5 |
p. 421-422 |
artikel |